BPC-157 is not FDA-approved for human therapeutic use and is classified as a Category 2 bulk drug substance by the FDA
Extensive research indicates its ability to promote healing, reduce inflammation, and improve cellular regeneration
Also, in a study conducted in China, both the frequency and quantity of maternal yogurt intake were associated with a dose-dependent reduction in the risk of eczema in infants aged 3 to 6 months
No, BPC-157 arginate capsules are sold only as research chemicals for in vitro and lab use
IV products can only be given by a healthcare provider. While there are other procedures available for increasing your glutathione levels as well, such as injectables and oral medications, in general, medical professionals find that IV often provides the most efficient and effective results
Cells contain high amounts of GSHabout 5 millimolar